Study of Affective Forecasting Skills in Post-traumatic Stress Disorder
NCT ID: NCT05268965
Last Updated: 2025-12-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
97 participants
OBSERVATIONAL
2022-02-28
2023-11-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predicting Treatment Response Using Psychophysiologic Reactivity Measures
NCT01571245
Identification of Markers of Post-Traumatic Stress Disorder (PTSD) Relapse
NCT01545505
Empathy in Post-traumatic Stress Disorder in Comparaison to a Control Population
NCT05617781
PTSD and Self-regulation: Coping, Emotional Regulation and Cognitive Control and Their Relationships to Symptom Management
NCT05400200
Early Detection of Patients at Risk of Developing a Post-traumatic Stress Disorder After a Stay in Intensive Care Unit
NCT03278171
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients meeting DSM-5 criteria for PTSD.
Experimental: group comparison
* Standardized psychiatric interview (Mini International Neuropsychiatric Interview MINI)
* State-Trait-Anxiety Inventory (Spielberger, 1993)
* Beck Depression Inventory (BDI-II, 1998)
* Cognitive Emotional Regulation Questionnaire (Jermann \& al., 2006) Participant installation and testing: 2 stages (forecasting on a computer, and exposure in virtual reality)
Task / affective forecasting:
* Step 1: forecasting about one's own emotional responses regarding pleasant, neutral and unpleasant scenarios
* Step 2: experience of the same scenarios in virtual reality
Group 2: Healthy controls who experienced a traumatic event but did not meet DSM-5 criteria for PTSD
Experimental: group comparison
* Standardized psychiatric interview (Mini International Neuropsychiatric Interview MINI)
* State-Trait-Anxiety Inventory (Spielberger, 1993)
* Beck Depression Inventory (BDI-II, 1998)
* Cognitive Emotional Regulation Questionnaire (Jermann \& al., 2006) Participant installation and testing: 2 stages (forecasting on a computer, and exposure in virtual reality)
Task / affective forecasting:
* Step 1: forecasting about one's own emotional responses regarding pleasant, neutral and unpleasant scenarios
* Step 2: experience of the same scenarios in virtual reality
Group 3: Healthy controls who did not experience a traumatic event
Experimental: group comparison
* Standardized psychiatric interview (Mini International Neuropsychiatric Interview MINI)
* State-Trait-Anxiety Inventory (Spielberger, 1993)
* Beck Depression Inventory (BDI-II, 1998)
* Cognitive Emotional Regulation Questionnaire (Jermann \& al., 2006) Participant installation and testing: 2 stages (forecasting on a computer, and exposure in virtual reality)
Task / affective forecasting:
* Step 1: forecasting about one's own emotional responses regarding pleasant, neutral and unpleasant scenarios
* Step 2: experience of the same scenarios in virtual reality
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Experimental: group comparison
* Standardized psychiatric interview (Mini International Neuropsychiatric Interview MINI)
* State-Trait-Anxiety Inventory (Spielberger, 1993)
* Beck Depression Inventory (BDI-II, 1998)
* Cognitive Emotional Regulation Questionnaire (Jermann \& al., 2006) Participant installation and testing: 2 stages (forecasting on a computer, and exposure in virtual reality)
Task / affective forecasting:
* Step 1: forecasting about one's own emotional responses regarding pleasant, neutral and unpleasant scenarios
* Step 2: experience of the same scenarios in virtual reality
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Understanding of informed consent and signature of the study participation form
* Giving informed, dated and signed consent
* Benefiting from health insurance coverage
* Normal or corrected visual and auditory acuity to achieve normality
* Group 1 : DSM-5 PTSD criteria, assessed using CAPS and PTSD Checklist for DSM-5 (PCL-5, Weathers \& al., 2013)
* Group 2: PTSD Criteria A only
Exclusion Criteria
* Visual or auditory sensory disability to participate in the study.
* Personal history of neurological disease or current neurological disease.
* Personal history of current psychiatric disorder or psychiatric disorder (excluding PTSD in patients in the experimental group), assessed via the MINI.
* Pregnant or breastfeeding women
* Consumption of toxic substances other than tobacco and alcohol.
* Minors or adults under guardianship, under judicial protection, persons deprived of liberty.
* Groups 2 and 3: personal history of psychiatric disorder or current psychiatric disorder and taking psychotropic drugs
* Group 1: personal history of psychiatric disorders or current psychiatric disorders other than anxiety, depressive, trauma and stress-related disorders and treatment with psychotropic drugs not stabilized
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guillaume Vaiva, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Lille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Usn Fontan - Linquette Chu Lille
Lille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-A01582-39
Identifier Type: OTHER
Identifier Source: secondary_id
2021_0385
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.